In agreement with our findings, activated CAPN5 induced increased inflammatory factors through TLR4/6 autoimmunity inflammation pathways in retinal degeneration in ADNIV patients [5, 6]. The gene discussed is TLR4; the disease is CAPN5-related vitreoretinopathy.